Severe chronic venous insufficiency (CVI) demonstrates as chronic, har
d-to-heal wounds of the lower extremity. The wound is the result of po
or skin perfusion due to a complex series of pathologic events, often
initiated by a deep vein thrombosis (DVT). As years pass, the DVT caus
es venous valvular damage and incompetence. The calf muscle pump fails
to augment venous return, and venous blood pressure is chronically el
evated upon standing. Mechanisms that normally prevent the transmissio
n of venous hypertension back upstream to the dermal microcirculation
are lost. Early dermal microvascular responses include increased fluid
filtration and edema. An inflammatory response induces white cell act
ivation and adhesion. It is thought that activated white cells are tra
pped in dermal capillaries and increase microvascular permeability. Pl
asma proteins leak into the tissue space, increasing the edema. Ischem
ic damage to the epidermis leads to epithelial cell necrosis and ulcer
ation. The ulcer is often slow to heal, due to inadequate perfusion an
d delivery of substrates required for proper wound healing. Current tr
eatments aim to improve calf pump function, reduce edema, improve perf
usion, and enhance wound healing.